ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)
Biotechnologia Acta Т. 17, No. 4 2024
P. 24-33, Bibliography 34, Engl.
UDC: 678.744.843
doi: https://doi.org/10.15407/biotech17.04.024
Full text: (PDF, in English)
USE OF MONOCLONAL ANTIBODIES TO HUMAN CYTOKINES IN DIAGNOSTIC AND ANALYTICAL STUDIES
National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute”
The use of human monoclonal antibodies in diagnostics and analytical studies is determined by the rapid development of technologies and approaches in the field of immunology and clinical laboratory diagnostics. Cytokines, as biologically active substances, play a key role in the regulation of immunity, inflammation and other physiological processes. The use of monoclonal antibodies to cytokines provides an opportunity to accurately determine their concentration and study the interaction with other molecules in clinical studies. The development of new diagnostic methods and analytical studies using monoclonal antibodies opened up prospects for increasing the accuracy and sensitivity of the determination of various diseases. This is especially important in the context of medicine, where accurate diagnosis becomes fundamental for choosing the optimal method.
Aim. The purpose of this work was to analyze the possibilities and advantages of using monoclonal antibodies to human cytokines in diagnostics and analytical studies, in particular their use in immunological biosensors, for monitoring the immunological status of patients after organ transplantation and diagnosing oncological diseases.
Methods. A comprehensive review of literature was conducted, encompassing multiple databases including Medline (PubMed), Web of Science, Scopus, Google Scholar and other relevant sources up to the year 2024. Keywords employed in the search included biosensors, cell markers, monoclonal antibodies, leukemia and Western blotting, transplantation.
Results. The paper investigated the potential and advantages of using human monoclonal antibodies to cytokines in medical diagnostics and analytical research. Their application in biosensors for precise determination of cytokine concentrations, immunophenotyping of blood cells and tissues, diagnosing tumors of various histogenesis, treating leukemias and lymphomas, determining immunological status and composition of the immune system cells were analyzed. The methodology of comprehensive immunological examination after organ transplantation and treatment, including аcquired immunodeficiency syndrome (AIDS), was also considered.
Conclusions. Monoclonal antibodies, effective in biosensors, are used in various fields such as biological research, clinical diagnostics, and environmental monitoring. Their use has limitations, such as cost, complexity of acquisition, and potential loss of signal sensitivity. Immunophenotyping allows the identification of blood cells based on their markers, which is important for hematological diagnostics. Immunohistochemical tissue studies use monoclonal antibodies to verify tumors and detect infectious diseases. Diagnosis of leukemias and lymphomas using monoclonal antibodies helps to determine tumor type and optimal treatment. Western blotting is used to determine proteins in tissues or blood, including confirming diseases such as Lyme disease or Human immunodeficiency virus (HIV infection. Flow cytometry, enzyme-linked immunosorbent assay (ELISA), and polymerase chain reaction (PCR) are also used in immunological laboratories for disease diagnosis and immune status assessment.
Key words: biosensors, cell markers, monoclonal antibodies, leukemia, Western blotting, transplantation.
References
1. Aly A.H., Mohamed B.A., Al-Dossari M., Awasthi S.K., Fouad E., Amin A.F. Ultra-high sensitive cancerous cells detection and sensing capabilities of photonic biosensor. Scientific Reports. 2023, 13(1): 19524. https://doi.org/10.1038/s41598-023-46667-y
2. Justino C.I.L., Duarte A.C., Rocha-Santos T.A.P. Critical overview on the application of sensors and biosensors for clinical analysis. Trends Analyt Chem. 2016, 85: 36–60. https://doi.org/10.1016/j.trac.2016.04.004
3. Bahadır E.B., Sezgintürk M.K. Applications of commercial biosensors in clinical, food, environmental, and biothreat/biowarfare analyses. Anal Biochem. 2015, 478: 107–120. https://doi.org/10.1016/j.ab.2015.03.011
4. Tzouvadaki I., Zapatero-Rodríguez J., Sébas- tien N., Giovanni de Micheli, O’Kennedy R., Carrara S. Memristive biosensors based on full-size antibodies and antibody fragments. Sensors and Actuators B: Chemical. 2019, 286: 346–352. https://doi.org/10.1016/j.snb.2019.02.001
5. Bahadır E.B., Sezgintürk M.K. Electrochemical biosensors for hormone analyses. Biosens Bioelectron. 2015, 68: 62–71. https://doi>.org/10.1016/j.bios.2014.12.054
6. Jung K., Fabiani F., Hoyer E., Lassak J. Bacterial transmembrane signalling systems and their engineering for biosensing. Open Biol. 2018, 8(4):180023. https://doi.org/10.1098/rsob.180023
7. Caballero B., Finglas P. M., Toldrá F. Encyclopedia of Food and Health. Academic Press. 2016, 3: 430–436.
8. Parikha Mehrotra. Biosensors and their applications — A review. Journal of Oral Biology and Craniofacial Research. 2016, 6(2): 153–159. https://doi.org/10.1016/j.jobcr.2015.12.002
9. Pedro R. Aranda, Germán A. Messina, Franco A. Bertolino, Sirley V. Pereira, Martín A. Fernández Baldo, Julio Raba. Nanomaterials in fluorescent laser-based immunosensors: Review and applications. Microchemical Journal. 2018, 141: 308–323. https://doi.org/10.1016/j.microc.2018.05.024
0. Burlage R.S., Tillmann J. Biosensors of bacterial cells. J. Microbiol. Methods. 2017, 138: 2–11. https://doi.org/10.1016/j.mimet.2016.12.023
11. Abolhasan R., Mehdizadeh A., Rashidi M.R., Aghebati-Maleki L., Yousefi M. Application of hairpin DNA-based biosensors with various signal amplification strategies in clinical diagnosis. Biosens Bioelectron. 2019, 129: 164–174. https://doi.org/10.1016/j.bios.2019.01.008
12. Alireza Nezami, Sadegh Dehghani, Rahim Nosrati, Negar Eskandari, Seyed Mohammad Taghdisi, Gholamreza Karimi. Nanomaterial-based biosensors and immunosensors for quantitative determination of cardiac troponins. Journal of Pharmaceutical and Biomedical Analysis. 2018, 159: 425–436. https://doi.org/10.1016/j.jpba.2018.07.031
13. Sanjay Kisan Metkar, Koyeli Girigoswami. Diagnostic biosensors in medicine – A review. Biocatalysis and Agricultural Biotechnology. 2019, 17: 271–283. https://doi.org/10.1016/j.bcab.2018.11.029
14. Fang-Ting Zhang, Liang-Yuan Cai, Ying-Lin Zhou, XinXiang Zhang. Immobilization-free DNA-based homogeneous electrochemical biosensors. TrAC Trends in Analytical Chemistry. 2016, 85(C): 17–32. https://doi.org/10.1016/j.trac.2016.08.012
15. Narwal V., Deswal R., Batra B., Kalra V., Hooda R., Sharma M. Rana J.S. Cholesterol biosensors: A review. Steroids. 2019, 143: 6–17. https://doi.org/10.1016/j.steroids.2018.12.003
16. Sawalha A.H. Clinical immunology: A special issue on epigenetics. Clin Immunol. 2018, 196: 1–2. https://doi.org/10.1016/j.clim.2018.11.012
17. Lang S. Clinical oncology-new developments. HNO. 2020, 68(9): 637–639. https://doi.org/10.1007/s00106-020-00911-3
18. Svintsitsky A.S., Gaevski P. Internal diseases. Textbook based on the principles of evidence based medicine. Praktichna Meditsina. 2018, 13: 1632. (In Ukrainian).
19. Pukhilya V.V., Starishko O.M. Immunohistochemistry as a method of diagnosing oncological pathologies of the organism. International Scientific and Practical Conference «Prospects and achievements in applied and basic sciences». 2021. https:/doi.org/10.46299/ISG.2021.I.IV
20. Rosha L.G. Optimization of immunohisto-chemical studies. Articles of the participants of the Fourth All-Ukrainian Multidisciplinary Conference “Scientific Research of the Black Sea”. 2018: 59–61.
21. Hemoblastosis. Lymphomas. Your medical encyclopedia. 2024.
22. Lanier O.L., Pérez-Herrero E., Andrea A.P.D., Bahrami K., Lee E., Ward D.M., Ayala-Suárez N., Rodríguez-Méndez S.L., Peppas N.A. Immunotherapy approaches for hematological cancers. iScience. 2022, 25(11): 105326. https://doi.org/10.1016/j.isci.2022.105326
23. Doevendans E, Schellekens H. Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies. Antibodies (Basel). 2019, 8(1): 21. https://doi.org/10.3390/antib8010021
24. The American Cancer Society medical and editorial content team. Monoclonal Antibodies for Chronic Lymphocytic Leukemia. The American Cancer Society edical and editorial content team. 2024.
25. Riyaz Tramboo S., Elkhalifa A.M.E., Quibtiya, S., Ali S.I., Nazir Shah N., Taifa S., Rakhshan R., Hussain Shah I., Ahmad Mir M., Malik M., Ramzan Z., Bashir N., Ahad S., Khursheed I., Bazie E. A., Mohamed Ahmed E., Elderdery A.Y., Alenazy F.O., Alanazi A., Alzahrani B., Nabi S.U. The critical impacts of cytokine storms in respiratory disorders. Heliyon, 2024, 10(9): e29769.
26. De Cock E., Kritikou P., Sandoval M., Tao S., Wiesner C., Carella A.M., Ngoh C., Waterboer T. Time Savings with Rituximab Subcutaneous Injection versus Rituximab Intravenous Infusion: A Time and Motion Study in Eight Countries. PLoS One. 2016, 11(6): e0157957.
27. Alfaleh M.A., Alsaab H.O., Mahmoud A.B. Phage Display Derived Monoclonal Antibodies: From Bench to Bedside. Front Immunol. 2020, 11: 1986. https://doi.org/10.3389/fimmu.2020.01986
28. Parrondo R.D., LaPlant B.R., Elliott J., Andre Fernandez, Caitlin J. Flott, Diedre Arrington, Dustin Chapin, Jade Brown, Saurav Das, Vivek Roy, Asher A. Chanan-Khan, Sikander Ailawadh. Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma. Blood Cancer J. 2024,14(1): 152. https://doi.org/10.3390/antib8010021
29. Jyothilekshmi I., Jayaprakash N.S. Trends in Monoclonal Antibody Production Using Various Bioreactor Syst. J. Microbiol. Biotechnol. 2021, 31(3): 349-357. https://doi.org/10.4014/jmb.1911.11066
30. Ratelle J.T., Sawatsky A.P., Beckman T.J. Quantitative Research Methods in Medical Education. Anesthesiology. 2019, 131(1): 23–35. https://doi.org/10.1097/ALN.0000000000002727
31. Kot M., Simiczyjew A., Wądzyńska J., Ziętek M., Matkowski R., Nowak D. Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib). Cell Commun Signal. 2024, 22(1): 410. https://doi.org/10.1186/s12964-024-01788-3
32. Kopcha V.S., Vasylieva N.A., Shkilna M.I. Diagnostic possibilities of immune blotting in borreliosis. Medical newspaper “Health of Ukraine of the 21st Century”. 2016, 11: 73–75.
33. Mezrich Joshua. When Death Becomes Life: Notes from a Transplant Surgeon. Budni vrach-transplantologa; EKSMO. 2019, 368.
34. Orlando G., Piemonti L., Ricordi C. Gruessner, Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas. Elsevier Academic Press. 2020, 2(2): 560.
35. Gabriel C. Oniscu, John L. R. Forsythe, Elizabeth A. Pomfret Transplantation Surgery. Springer Berlin Heidelberg. 2019, 585.
36. Orlando G., Piemonti L., Ricordi C. Transplantation, bioengineering and regeneration of the endocrine pancreas. Elsevier Academic Press. 2020, 1: 890.
37. Chopyak V.V., Potyomkina H.O., Havryliuk A.M. Clinical Immunology and Allergology: Handbook for Practical Classes. Meditsyna. 2017. 224.
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2024